Among the pre-NAC samples, 4/6 patients (66.7%) were positive for overall PD-L1 expression (stroma and tumor together), 3/6 (50%) were positive for tumor PD-L1 expression, and 4/6 (66.7%) were positive for stromal PD-L1 expression. The gene discussed is CD274; the disease is neoplasm.